文献速递免疫规划

孟加拉国新冠疫苗接种成人中持续高抗SARS-CoV-2 IgG与IFN-γ正相关相关的IFN-γ基因近端启动子区遗传与表观遗传分析

Genetic and epigenetic analyses of IFN-γ gene proximal promoter region underlying positive correlation between persistently high anti-SARS-CoV-2 IgG and IFN-γ among COVID-19 vaccinated Bangladeshi adults.
PubMed 文献 · Vaccine · 2024-07-30

研究纳入200名新冠疫苗接种成人,按血浆抗SARS-CoV-2 IgG分为血清阳性和阴性组,分析IgG与IFN-γ水平相关性,并对部分对象行IFN-γ基因近端启动子测序及相对去甲基化评估。在持续高IgG滴度(IgG>Q3且接种后>180天)的血清阳性组中,IFN-γ与抗SARS-CoV-2 IgG呈统计学显著正相关(r=0.492,p=0.018);IFN-γ近端启动子去甲基化与血浆IFN-γ水平无显著相关。

要点

  • 持续高IgG组(IgG>Q3且接种后>180天)IFN-γ与抗SARS-CoV-2 IgG呈正相关(r=0.492,p=0.018)。
  • 一名血清阴性个体检出5'-UTR杂合变异rs776667149:C>T,可能影响PKR介导的IFN-γ mRNA翻译衰减。
  • HAR个体中IFN-γ近端启动子去甲基化与血浆IFN-γ水平无显著相关。

核心结论

  • 本研究显示孟加拉国新冠疫苗接种人群存在一定程度的SARS-CoV-2体液免疫。
  • 本研究提示血浆IFN-γ可能在维持持续抗SARS-CoV-2 IgG水平中发挥作用,并需结合遗传和/或表观遗传基础进一步研究以充分确立其在新冠疫苗接种中的保护性。

研究设计与样本

  • 研究纳入200名新冠疫苗接种成人,依据血浆抗SARS-CoV-2 IgG分为血清阳性组和血清阴性组。
  • 对血清阴性(21<接种后天数≤180,n=11)和血清阳性(IgG>Q3且接种后天数>180,n=24)两个亚组行IFN-γ基因近端启动子区核苷酸测序。
  • 对后者亚组评估IFN-γ近端启动子相对去甲基化及其与血浆IFN-γ和IgG水平的相关性。

主要发现

  • 在持续高IgG滴度(IgG>Q3且接种后>180天)的血清阳性组中,IFN-γ与抗SARS-CoV-2 IgG呈统计学显著正相关(r=0.492,p=0.018)。
  • 一名血清阴性个体检出5'-UTR杂合变异(rs776667149:C>T),提示可能影响PKR介导的IFN-γ mRNA翻译衰减。
  • 在接种后天数>180天的HAR个体中,IFN-γ近端启动子去甲基化与血浆IFN-γ水平无显著相关(r=0.14,p=0.679)。
  • 在接种后天数<180天的HAR个体中,IFN-γ近端启动子去甲基化与血浆IFN-γ水平无显著相关(r=-0.062,p=0.693)。

局限性

  • 本研究结论指出血浆IFN-γ可能在维持持续抗SARS-CoV-2 IgG水平中发挥作用,但需结合遗传和/或表观遗传基础进一步研究以充分确立其在新冠疫苗接种中的保护性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IFN-γ is an immunological modulator influencing IgG isotype and concentration, which present a correlate of protection to evaluate vaccine efficacy. As transiently expressed, stable genetic and epigenetic signatures of the cytokine's expression may exist. This study investigates correlation between plasma IFN-γ and anti-SARS-CoV-2 IgG levels, seeking genetic polymorphisms and epigenetic variations within the IFN-γ gene proximal promoter. 200 COVID-19-vaccinated adults were classified into seropositive and seronegative groups based on plasma anti-SARS-CoV-2 IgG. Upon correlation analysis between anti-SARS-CoV-2 IgG and IFN-γ levels, IFN-γ gene proximal promoter region was subjected to nucleotide sequencing for two subsets: seronegative (21 < Days post-vaccination ≤180, n = 11) and seropositive (IgG > Q3 and Days post-vaccination >180, n = 24). Relative unmethylation of IFN-γ proximal promoter was assessed for the latter subset and its correlation with plasma IFN-γ and IgG levels was evaluated. A statistically significant positive correlation (r = 0.492, p = 0.018) was observed between IFN-γ and anti-SARS-CoV-2 IgG in the seropositive group with persistently high IgG titre (IgG > Q3, Days elapsed post-vaccination >180). A heterozygous 5'-UTR variant (rs776667149:C>T) identified in one seronegative individual revealed a potential impact on PKR-mediated translational attenuation of IFN-γ mRNA. No significant correlation was found between IFN-γ proximal promoter unmethylation and its plasma levels among HAR individuals with Days post-vaccination of either >180 (r = 0.14, p = 0.679) or < 180 (r = -0.062, p = 0.693). This study demonstrates an extent of humoral immunity against SARS-CoV-2 among COVID-19 vaccinated Bangladeshi population. This study suggests plasma IFN-γ may play a role in maintaining persistent anti-SARS-CoV-2 IgG levels, which warrants further investigation along with genetic and/or epigenetic basis to fully establish its protective nature in COVID-19 vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Tahsin A, Bhattacharjee P, Al Saba A, et al. Genetic and epigenetic analyses of IFN-γ gene proximal promoter region underlying positive correlation between persistently high anti-SARS-CoV-2 IgG and IFN-γ among COVID-19 vaccinated Bangladeshi adults. Vaccine. 2024. PMID: 39079811. doi:10.1016/j.vaccine.2024.126157

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。